Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 2 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Neoplasms 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Carcinosarcoma 1 Carcinoma, Renal Cell 1

Interventions

Doxorubicin 19 Radiotherapy 10 Ifosfamide 10 apatinib 9 anlotinib 8 Cyclophosphamide 8 camrelizumab 7 Vincristine 5 Dactinomycin 5 toripalimab 3 Trabectedin 3 Radiation Dose Hypofractionation 3 Ipilimumab 3 Gemcitabine 3 Etoposide 3 Docetaxel 3 selinexor 2 ribociclib 2 envafolimab 2 brostallicin 2 Topotecan 2 Thalidomide 2 Temozolomide 2 Sorafenib 2 Oncolytic Virotherapy 2 Nivolumab 2 Neoadjuvant Therapy 2 Melphalan 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Sarcoma × cediranib × Clear all

NCT01337401 2019-01-24

CASPS

Institute of Cancer Research, United Kingdom

Phase 2 Unknown

Sarcoma, Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon ⚡